ENTA

Enanta Pharmaceuticals Inc

• Benzinga·1d ago

  European Medicines Agency Announces Meeting highlights From The Committee For Medicinal Products for Human Use, May 18-21

• Simply Wall St·05/14 22:44

  Enanta Pharmaceuticals (ENTA) Q2 Loss Improvement Tests Bearish Profitability Narratives

• Simply Wall St·05/13 18:55

  Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

• TipRanks·05/12 15:10

  Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Orchestra BioMed Holdings (OBIO)

• TipRanks·05/11 21:39

  Enanta reports Q2 EPS (45), consensus (49c)

• Reuters·05/11 20:11

  Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs

• Benzinga·05/11 20:05

  Enanta Pharma Q2 EPS $(0.45) Beats $(0.49) Estimate, Sales $17.159M Beat $17.092M Estimate

• Seeking Alpha·05/11 20:05

  Enanta Pharma GAAP EPS of -$0.45 beats by $0.04, revenue of $17.16M beats by $0.07M

• PUBT·05/11 20:01

  Enanta FY26 Q2 net loss narrows to $13.1 million; revenue rises to $17.2 million

• Reuters·05/11 20:01

  BRIEF-Enanta Pharmaceuticals Q2 Revenue USD 17.159 Million Vs. IBES Estimate USD 17.1 Million

• Dow Jones·05/11 20:01

  Press Release: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026

• Dow Jones·05/11 20:01

  *Enanta Pharmaceuticals 2Q Rev $17.2M >ENTA

• Dow Jones·05/11 20:01

  Press Release: Enanta Pharmaceuticals Reports -3-

• Dow Jones·05/11 20:01

  Press Release: Enanta Pharmaceuticals Reports -2-

• Dow Jones·05/11 20:01

  *Enanta Pharmaceuticals 2Q Loss $13.1M >ENTA